Biotech · Private company
Altasciences Company Inc.
Track this companyFree. Adds Altasciences Company Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials124 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- KratomPhase 1 · SafetyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Phase 1 Study Involving SAB01 and Healthy ParticipantsPHASE1 · RECRUITING · started Aug 31, 2026ClinicalTrials.gov NCT07815561 · fetched Nov 12, 2026
- Phase 1 Study of SBS-147 in Healthy AdultsPHASE1 · RECRUITING · started Jan 8, 2026ClinicalTrials.gov NCT07335913 · fetched Nov 12, 2026
- A Study of SPY003-207 in Healthy VolunteersPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 10, 2025ClinicalTrials.gov NCT06873724 · fetched Nov 12, 2026
- A Study of SPY002-091 in Healthy VolunteersPHASE1 · COMPLETED · started Nov 26, 2024ClinicalTrials.gov NCT06672718 · fetched Nov 12, 2026
- A Study of SPY002-072 in Healthy VolunteersPHASE1 · COMPLETED · started Nov 18, 2024ClinicalTrials.gov NCT06622070 · fetched Nov 12, 2026
- A Study of SPY001-001 in Healthy VolunteersPHASE1 · COMPLETED · started Jun 6, 2024ClinicalTrials.gov NCT06448247 · fetched Nov 12, 2026
- Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid ExperiencePHASE1 · COMPLETED · started Aug 16, 2023ClinicalTrials.gov NCT06072170 · fetched Nov 12, 2026
- An Open-label DDI Study of Omaveloxolone in Healthy SubjectsPHASE1 · COMPLETED · started Jul 5, 2023ClinicalTrials.gov NCT05909644 · fetched Nov 12, 2026
- Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the HeartPHASE1 · COMPLETED · started May 12, 2023ClinicalTrials.gov NCT05933447 · fetched Nov 12, 2026
- Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023PHASE1 · COMPLETED · started Apr 6, 2022ClinicalTrials.gov NCT05354349 · fetched Nov 12, 2026
- A Single-Dose, Randomized, Open-Label, 2-Way Crossover Study to Evaluate the Dose-Proportionality, Safety, and Tolerability of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) in Healthy Japanese and Chinese SubjectsPHASE1 · COMPLETED · started Mar 18, 2022ClinicalTrials.gov NCT07464535 · fetched Nov 12, 2026
- TH1902 in Patients With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 4, 2021ClinicalTrials.gov NCT04706962 · fetched Nov 12, 2026